Invivyd, Inc. (Nasdaq: IVVD) specializes in developing potent, virus-resistant medicines using a proprietary integrated technology platform. The company focuses on creating best-in-class antibodies through advanced assessment and adaptation techniques. In March 2024, Invivyd received emergency use authorization for a monoclonal antibody, highlighting its innovation in treating immune-compromised patients.
Invivyd is seeking a Strategic Account Manager to drive antibody-based therapies and protect vulnerable patients. This role involves leading territory business plans, educating customers, collaborating with cross-functional teams, and utilizing data to optimize sales efforts. The company focuses on combating COVID-19 and developing innovative antibody therapies.
Invivyd, Inc. (Nasdaq: IVVD) specializes in developing potent, virus-resistant medicines using a proprietary integrated technology platform. The company focuses on creating best-in-class antibodies through advanced assessment and adaptation techniques. In March 2024, Invivyd received emergency use authorization for a monoclonal antibody, highlighting its innovation in treating immune-compromised patients.